Food and Drug Administration
Nonclinical
Studies Subcommittee of the
ADVISORY
COMMITTEE FOR PHARMACEUTICAL SCIENCE
March
9, 2000
Slides
FDA
Objectives, James T. MacGregor ppt
htm
Biomarkers, Introduction & Recommendations for Biomarkers Projects, Frank Sistare, PhD ppt htm
NIH Research Activities, Gregory Downing, PhD, NIH ppt htm
Accessible Toxicity Biomarker Morning Presentations, Malcolm York, M.Phil. ppt htm
Proteomics and Safety Biomarker Discover, Gordon Holt, PhD, Oxford GlycoSciences ppt htm pdf
Pharmaceutical Proteomics, Leigh Anderson, PhD, Large Scale Proteomics Corp. ppt htm
TaqMan Gene Expression Arrays for Accurate Quantification of Toxicity Targets, Federico Goodsaid, PhD, PCR R&D ppt htm pdf
Micro-PET: Experiences with Small Animal Imaging, Simon Cherry, PhD, Crump Institute, UCLA ppt htm pdf
National Cancer Institute, Biomedical Imaging Program, James Tatum, MD pdf
Proposal to Form Expert Working Group on Imaging, Science Issues, Jerry Collins, MD ppt htm
Open Public Hearing
Identification of Surrogate Markers for Predicting Drug Responses, H. Ralph Snodgrass Ph.D., VistaGen Inc. ppt htm